AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Mawson Infrastructure Group Inc. Director's Dealing 2021

Mar 17, 2021

35202_dirs_2021-03-16_c8f5f7cc-c912-475a-b926-8fd765cd99a1.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2021-03-09

Reporting Person: Martin Gregory John Walton (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	558668	Direct